Tofidence 20 mg/mL
Tocilizumab · INJECTION · Biogen MA Inc
Tocilizumab is a prescription injection that blocks interleukin-6 receptors to reduce inflammation in the body, used to treat conditions like rheumatoid arthritis, giant cell arteritis, and certain severe inflammatory conditions. It is administered intravenously by a healthcare provider.
Key Facts
- Brand Name
- Tofidence
- Generic Name
- Tocilizumab
- NDC Code (Product)
64406-022- Manufacturer
- Biogen MA Inc
- Strength
- 20 mg/mL
- Dosage Form
- INJECTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761354
- Drug Class
- Interleukin-6 Receptor Antagonist [EPC]
- Marketing Start
- 05/01/2024
Recall History
No Recall HistoryFrequently Asked Questions
What is Tofidence used for?
Tocilizumab is a prescription injection that blocks interleukin-6 receptors to reduce inflammation in the body, used to treat conditions like rheumatoid arthritis, giant cell arteritis, and certain severe inflammatory conditions. It is administered intravenously by a healthcare provider.
Is Tofidence a controlled substance?
Tofidence is not classified as a controlled substance by the DEA.
What is the generic name for Tofidence?
The generic name for Tofidence is Tocilizumab. There are 9 other brand versions of Tocilizumab.
What is the NDC code for Tofidence 20 mg/mL?
The NDC (National Drug Code) for Tofidence 20 mg/mL is 64406-022, listed by Biogen MA Inc.